Detalhe da pesquisa
1.
A phase 2 trial of zanidatamab in HER2-overexpressed advanced endometrial carcinoma and carcinosarcoma (ZW25-IST-2).
Gynecol Oncol
; 182: 75-81, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38262242
2.
Targeting HER2-mutant metastatic cervical cancer with neratinib: Final results from the phase 2 SUMMIT basket trial.
Gynecol Oncol
; 181: 162-169, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38211393
3.
Procedural interventions for oligoprogression during treatment with immune checkpoint blockade in gynecologic malignancies: a case series.
Int J Gynecol Cancer
; 34(4): 594-601, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38296517
4.
Durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial cancer or endometrial carcinosarcoma: A randomized open-label phase 2 study.
Gynecol Oncol
; 169: 64-69, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36512912
5.
Integration of clinical sequencing and immunohistochemistry for the molecular classification of endometrial carcinoma.
Gynecol Oncol
; 174: 262-272, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37245486
6.
Gastric-type adenocarcinoma of the cervix: Clinical outcomes and genomic drivers.
Gynecol Oncol
; 167(3): 458-466, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36253302
7.
Treatment of ovarian clear cell carcinoma with immune checkpoint blockade: a case series.
Int J Gynecol Cancer
; 32(8): 1017-1024, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35545291
8.
Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study.
Lancet Oncol
; 22(9): 1290-1300, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34339623
9.
A phase I open-label study of selinexor with paclitaxel and carboplatin in patients with advanced ovarian or endometrial cancers.
Gynecol Oncol
; 160(1): 71-76, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33139041
10.
Genetic and molecular subtype heterogeneity in newly diagnosed early- and advanced-stage endometrial cancer.
Gynecol Oncol
; 161(2): 535-544, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33622519
11.
Utility of serum CA-125 monitoring in patients with ovarian cancer undergoing immune checkpoint inhibitor therapy.
Gynecol Oncol
; 158(2): 303-308, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32507515
12.
Neratinib in patients with HER2-mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial.
Gynecol Oncol
; 159(1): 150-156, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32723675
13.
Clinical outcomes of patients with POLE mutated endometrioid endometrial cancer.
Gynecol Oncol
; 156(1): 194-202, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31757464
14.
Patient-Physician Communication in the 21st Century.
Trends Immunol
; 37(6): 347-349, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27156780
15.
Subsequent therapies and survival after immunotherapy in recurrent ovarian cancer.
Gynecol Oncol
; 155(1): 51-57, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31421916
16.
Early disease progression and treatment discontinuation in patients with advanced ovarian cancer receiving immune checkpoint blockade.
Gynecol Oncol
; 152(2): 251-258, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30470581
17.
Options for Adjuvant Therapy for Uterine Leiomyosarcoma.
Curr Treat Options Oncol
; 19(2): 7, 2018 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29417238
18.
Emerging Tissue and Blood-Based Biomarkers that may Predict Response to Immune Checkpoint Inhibition.
Curr Oncol Rep
; 18(4): 21, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26922327
19.
MyPathway Human Epidermal Growth Factor Receptor 2 Basket Study: Pertuzumab + Trastuzumab Treatment of a Tissue-Agnostic Cohort of Patients With Human Epidermal Growth Factor Receptor 2-Altered Advanced Solid Tumors.
J Clin Oncol
; 42(3): 258-265, 2024 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37793085
20.
Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses.
Nat Med
; 30(5): 1330-1338, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38653864